AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

COCHLEAR LTD

164.625

+3.2452.01%

Volume:72.18K

Turnover:11.84M

Market Cap:10.77B

PE:31.25

High:165.900

Open:163.290

Low:161.130

Close:161.380

52wk High:313.284

52wk Low:160.000

Shares:65.40M

Float Shares:65.14M

Volume Ratio:0.35

T/O Rate:0.11%

Dividend:4.30

Dividend Rate:2.61%

EPS(TTM):5.268

EPS(LYR):5.943

ROE:18.15%

ROA:11.28%

PB:5.56

PE(LYR):27.70

Loading ...

Overview Company News Filings

Cochlear Bulls See No Near-Term Gene Therapy Impact -- Market Talk

3 top blue-chip ASX 200 shares that look dirt cheap right now

I'm listening to Warren Buffett and loading up on cheap ASX shares

CSL and these ASX 200 stocks just hit 52-week lows: Should you buy the dip?

Why Cochlear and ResMed shares could be strong buys

Cochlear Poised for Medium-Term Growth on Nexa Launch, Jefferies Says

MT Newswires Live

Cochlear Offers Quality Despite Currency Headwind -- Market Talk

Australian shares: A once-in-a-decade chance to build wealth?

Where I'd invest $10,000 in ASX 200 blue-chip shares right now

5 things to watch on the ASX 200 on Monday

26 ASX shares with ex-dividend dates next week

IotaMotion Strengthens Leadership Position in Robotic Cochlear Implant Surgery with Issuance of New U.S. Patent

Top 10 ASX 200 Stocks to Consider Following Market Downturn

What Cochlear (ASX:COH)'s Smart, Upgradeable Implant Launch in India Means For Shareholders

Simply Wall St.

Organic Growth in Australia's Healthcare Services Likely Due to Increased Availability of Bulk-Billing General Practitioners, Jefferies Says

MT Newswires Live

Assessing Cochlear (ASX:COH) Valuation After Softer Half Year Results And Steady Interim Dividend

Simply Wall St.

Cochlear (ASX:COH) Holds Dividend as Profit Guidance Softens – What Is Management Signaling?

Simply Wall St.

Cochlear (ASX:COH) Valuation After Profit Drop Nexa Delays And Lowered Outlook

Simply Wall St.

Cochlear (ASX:COH) Has Affirmed Its Dividend Of A$2.15

Simply Wall St.

Cochlear Bull Thinks Selloff Was Emotion-Driven -- Market Talk

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/COH.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"COH.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"COH.AU\",,,,,undefined,":{"symbol":"COH.AU","market":"AU","secType":"STK","nameCN":"COCHLEAR LTD","latestPrice":164.625,"timestamp":1774409118220,"preClose":161.38,"halted":0,"volume":72182,"delay":0,"changeRate":0.020107820052051088,"nameEN":"COCHLEAR LTD","floatShares":65138365,"shares":65398462,"eps":5.268067,"marketStatus":"Trading","change":3.245,"latestTime":"03-25 14:25:18 AEDT","open":163.29,"high":165.9,"low":161.13,"amount":11837180,"amplitude":0.029558,"askPrice":164.64,"askSize":9,"bidPrice":164.59,"bidSize":4,"shortable":3,"etf":0,"ttmEps":5.268067,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1774414800000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":161.38,"dividendRate":0.02612,"openAndCloseTimeList":[[1774393200000,1774414800000]],"volumeRatio":0.351804,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"COH.AU","preClose":161.38,"auctionPrice":163.29,"auctionVolume":2786,"auctionTime":1774393143927,"referenceTime":1774344603091,"auction":1,"marketStatus":"盘前竞价","timestamp":1774393143927}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"COH.AU\",,,,,undefined,":{"symbol":"COH.AU","floatShares":65138365,"roa":"11.28%","roe":"18.15%","lyrEps":5.943021,"volumeRatio":0.351804,"shares":65398462,"dividePrice":4.3,"high":165.9,"amplitude":0.029558,"preClose":161.38,"low":161.13,"week52Low":160,"pbRate":"5.56","psRate":"4.60","week52High":313.284,"institutionHeld":0,"latestPrice":164.625,"committee":-0.666667,"eps":5.268067,"divideRate":0.02612,"volume":72182,"delay":0,"ttmEps":5.268067,"open":163.29,"prevYearClose":257.41,"prevWeekClose":164.62,"prevMonthClose":196.529,"prevQuarterClose":257.41,"fiveDayClose":170.28,"twentyDayClose":194.544,"sixtyDayClose":257.222,"dividendPayoutRate":0.7151245132736365,"dividendGrowthYears":4,"dividendGrowthRate":0.13333333333333333,"fiveYearAvgDividendRate":0.011947843137511144},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/COH.AU\",params:#limit:5,,,undefined,":[{"date":"2026-03-19","symbol":"COH.AU","amount":2.15,"announcedDate":"2026-02-12","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-20","name":"COCHLEAR LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-13","payableDate":"2026-03-20","currency":"AUD","dateTimestamp":1773838800000,"payDate":"2026-04-13"},{"date":"2026-02-13","symbol":"COH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770937200000,"name":null,"time":"","dateTimestamp":1770901200000,"actualEps":null},{"date":"2025-09-18","symbol":"COH.AU","amount":2.15,"announcedDate":"2025-08-15","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-19","defaultRemindTime":1758153600000,"name":"COCHLEAR LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-13","payableDate":"2025-09-19","currency":"AUD","dateTimestamp":1758117600000,"payDate":"2025-10-13"},{"date":"2025-08-15","symbol":"COH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755216000000,"name":null,"time":"","dateTimestamp":1755180000000,"actualEps":null},{"date":"2025-03-20","symbol":"COH.AU","amount":2.15,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-03-21","name":"COCHLEAR LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-14","payableDate":"2025-03-21","currency":"AUD","dateTimestamp":1742389200000,"payDate":"2025-04-14"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"COH.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2021-03-25","recordDate":"2021-03-26","paymentDate":"2021-04-20","value":1.15,"currency":"AUD"},{"executeDate":"2021-09-23","recordDate":"2021-09-24","paymentDate":"2021-10-18","value":1.4,"currency":"AUD"},{"executeDate":"2022-03-28","recordDate":"2022-03-29","paymentDate":"2022-04-21","value":1.55,"currency":"AUD"},{"executeDate":"2022-09-21","recordDate":"2022-09-23","paymentDate":"2022-10-17","value":0.87,"currency":"AUD"},{"executeDate":"2023-03-21","recordDate":"2023-03-22","paymentDate":"2023-04-14","value":1.0075,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"COH.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622401400","title":"Cochlear Bulls See No Near-Term Gene Therapy Impact -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2622401400","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622401400?lang=en_us&edition=fundamental","pubTime":"2026-03-25 08:18","pubTimestamp":1774397880,"startTime":"0","endTime":"0","summary":"0018 GMT - Cochlear's bulls at UBS reassure investors that any impact on demand from gene therapies for congenital hearing loss remains many years away. Analysts at the investment bank acknowledge that therapy efficacy data is encouraging but stress that there will be no near-term material impact on the Australia-listed hearing-implant maker. For now, they tell clients in a note that they expect Cochlear's new Nexa implant to boost the company's market share. A recent sell-off in the stock is just an opportunity, they add. UBS keeps a buy rating and A$302.00 target price on the stock, which is up 1.5% at A$163.77. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","COH.AU"],"gpt_icon":0},{"id":"2622016321","title":"3 top blue-chip ASX 200 shares that look dirt cheap right now","url":"https://stock-news.laohu8.com/highlight/detail?id=2622016321","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622016321?lang=en_us&edition=fundamental","pubTime":"2026-03-25 05:29","pubTimestamp":1774387785,"startTime":"0","endTime":"0","summary":"A number of popular blue-chip ASX 200 shares recently hit 52-week lows or worse. While this is disappointing, it could have created a buying opportunity for patient investors. For example, listed belo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/25/3-top-blue-chip-asx-200-shares-that-look-dirt-cheap-right-now/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/25/3-top-blue-chip-asx-200-shares-that-look-dirt-cheap-right-now/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4535","BK7007","BK7097","BK4588","CSL.AU","TWE.AU","BK7511","BK7508","BK4585","COH.AU","BK7505","BK7067","BK7501"],"gpt_icon":0},{"id":"2622090681","title":"I'm listening to Warren Buffett and loading up on cheap ASX shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2622090681","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622090681?lang=en_us&edition=fundamental","pubTime":"2026-03-25 03:00","pubTimestamp":1774378800,"startTime":"0","endTime":"0","summary":"Warren Buffett has always had a simple philosophy. Be greedy when others are fearful. Right now, there's definitely a lot of fear in the market. A number of high-quality ASX shares have been pushed do","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/25/im-listening-to-warren-buffett-and-loading-up-on-cheap-asx-shares-2/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/25/im-listening-to-warren-buffett-and-loading-up-on-cheap-asx-shares-2/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BRKU","LU0256863811.USD","LU2168563687.JPY","LU0251142724.SGD","LU0683600562.USD","IE00BWXC8680.SGD","FLT.AU","BK7095","BRKD","ARR","BK7503","IE00BKDWB100.SGD","LU1363072403.SGD","COH.AU","LU2168564222.USD","WTC.AU","LU0640476718.USD","LU0048573561.USD","LU0787776722.HKD","BK4534","IE00B1XK9C88.USD","LU0210528500.USD","LU1914381329.SGD","BK4588","LU2168564065.EUR","ARR.AU","BK4585","BRKC","LU0251131958.USD","LU0053666078.USD","LU0417517546.SGD","LU0648001328.SGD","BK7103","LU0149725797.USD","HK0000914660.USD","BK4110","IE00B775SV38.USD","IE00BJLML261.HKD","BK7070","BK7007","LU0980610538.SGD","LU0170899867.USD","LU0154236417.USD","LU0157215616.USD","BRKW","IE00BK4W5L77.USD","SIG.AU","BK7016","LU1571399168.USD"],"gpt_icon":1},{"id":"2620290420","title":"CSL and these ASX 200 stocks just hit 52-week lows: Should you buy the dip?","url":"https://stock-news.laohu8.com/highlight/detail?id=2620290420","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620290420?lang=en_us&edition=fundamental","pubTime":"2026-03-19 11:03","pubTimestamp":1773889412,"startTime":"0","endTime":"0","summary":"It's been a tough session for the market. After a weak lead from Wall Street overnight, the ASX 200 is down around 1.55% at the time of writing on Thursday. That takes losses for March to roughly 7.5%, which is a meaningful pullback in such a short period.Whenever markets fall like this, quality stocks tend to get dragged down with everything else.That's exactly what we're seeing right now, with several well-known ASX 200 stocks hitting 52-week lows. The key question is: is this an opportunity for investors?CSL has been under pressure for a while now, and this latest selloff has pushed it to fresh lows.Sentiment has clearly turned cautious, but I don't think the long-term story has changed in any meaningful way.This is still one of Australia's highest-quality healthcare companies, with global scale, strong margins, and a long track record of innovation.Short-term earnings noise and investor concerns can move the share price around, but over time, businesses like CSL tend to reflect the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/19/csl-and-these-asx-200-stocks-just-hit-52-week-lows-should-you-buy-the-dip/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/19/csl-and-these-asx-200-stocks-just-hit-52-week-lows-should-you-buy-the-dip/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["CSL","BK7508","SG9999004303.SGD","LU1169589451.USD","BK7063","BK7511","SGXZ23171101.USD","BK7501","ALL.AU","BK4086","AMC.AU","COH.AU","LU1169590202.USD","BK7007","BK7078","CSL.AU","BK7067","LU0728928796.USD"],"gpt_icon":0},{"id":"2620402124","title":"Why Cochlear and ResMed shares could be strong buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2620402124","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620402124?lang=en_us&edition=fundamental","pubTime":"2026-03-18 08:39","pubTimestamp":1773794353,"startTime":"0","endTime":"0","summary":"If you want exposure to the healthcare sector, then it could be worth hearing what Wilsons is saying. That's because the broker recently named the two popular ASX healthcare shares in this article as ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/18/why-cochlear-and-resmed-shares-could-be-strong-buys/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/18/why-cochlear-and-resmed-shares-could-be-strong-buys/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4548","BK4082","BK4588","COH.AU","IE00B5TLWC47.USD","LU2008162690.USD","BK7501","BK7007","BK4585","LU0170899867.USD","LU2177674079.SGD","BK4567","BK4504","RMD","RMD.AU"],"gpt_icon":0},{"id":"2620102874","title":"Cochlear Poised for Medium-Term Growth on Nexa Launch, Jefferies Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2620102874","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620102874?lang=en_us&edition=fundamental","pubTime":"2026-03-17 13:02","pubTimestamp":1773723720,"startTime":"0","endTime":"0","summary":"Cochlear (ASX:COH) is expected to see solid operational performance and increased market share from its new Nexa cochlear implant system, despite short-term currency headwinds, Jefferies said in a Tue","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","COH.AU"],"gpt_icon":0},{"id":"2620413652","title":"Cochlear Offers Quality Despite Currency Headwind -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2620413652","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620413652?lang=en_us&edition=fundamental","pubTime":"2026-03-17 08:19","pubTimestamp":1773706740,"startTime":"0","endTime":"0","summary":"0019 GMT - Cochlear's bull at Jefferies remains confident in the underlying strength of the hearing-implant maker despite the earnings headwind of a stronger Australian dollar. Analyst David Stanton lowers his EPS forecast for the current fiscal year by 7%--and for fiscal 2027 by 9%--citing the recent strengthening of the local currency against the U.S. dollar and Euro, as well as a lower comparable earnings multiple. Stanton says Cochlear remains a quality business. Pointing to feedback from hearing-industry professionals, Stanton adds that Cochlear's new Nexa implant will drive market-share gains over at least the medium term. Jefferies lowers its target price by 6.25% to A$285.00 and keeps a buy rating on the stock, which is flat at A$173.10. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","COH.AU"],"gpt_icon":0},{"id":"2620497799","title":"Australian shares: A once-in-a-decade chance to build wealth?","url":"https://stock-news.laohu8.com/highlight/detail?id=2620497799","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620497799?lang=en_us&edition=fundamental","pubTime":"2026-03-17 06:30","pubTimestamp":1773700200,"startTime":"0","endTime":"0","summary":"At first glance, the Australian share market doesn't look particularly cheap.  Even after the recent pullback driven by escalating tensions in the Middle East, the S&P/ASX 200 Index (ASX: XJO) is stil","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/17/australian-shares-a-once-in-a-decade-chance-to-build-wealth/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/17/australian-shares-a-once-in-a-decade-chance-to-build-wealth/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["SIG.AU","BK7063","BK7505","BK7501","BK7078","JHX.AU","BK7049","BK7007","WTC.AU","COH.AU","PME.AU","TLX.AU","BK7511","XJO.AU","BK7016","AMC.AU","XAO.AU","BK7503","BK7107","BK7044","CSL.AU","TPW.AU","BK7070","BK7103","TWE.AU","XKO.AU","BK7097","BK7508","FLT.AU","ALL.AU","BK7094","XRO.AU","BK7067"],"gpt_icon":0},{"id":"2619485483","title":"Where I'd invest $10,000 in ASX 200 blue-chip shares right now","url":"https://stock-news.laohu8.com/highlight/detail?id=2619485483","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619485483?lang=en_us&edition=fundamental","pubTime":"2026-03-16 05:45","pubTimestamp":1773611100,"startTime":"0","endTime":"0","summary":"When I think about investing in blue-chip shares, I'm usually looking for a few key things.First, I want businesses with strong competitive positions. Second, I want companies that have proven they can grow over long periods of time. And finally, I like businesses that operate in industries with favourable long-term trends.The ASX 200 has plenty of high-quality blue-chip shares worth considering. But if I had $10,000 ready to invest today, these are three that I find particularly appealing right now.Woolworths might not be the most exciting company on the ASX, but that's part of what I like about it.Supermarkets are a classic defensive business. People still need to buy groceries regardless of what the economy is doing, which helps provide a steady stream of revenue.I also think the company's investments in technology, online shopping, and supply chain efficiency could help support steady earnings growth over time.The company also invests heavily in research and development, which help","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/16/where-id-invest-10000-in-asx-200-blue-chip-shares-right-now/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/16/where-id-invest-10000-in-asx-200-blue-chip-shares-right-now/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["MQG.AU","BK7046","BK7511","BK7007","WOW.AU","BK4588","COH.AU","BK4585","BK4535","BK7501","BK7040"],"gpt_icon":0},{"id":"2619002141","title":"5 things to watch on the ASX 200 on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2619002141","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619002141?lang=en_us&edition=fundamental","pubTime":"2026-03-16 02:33","pubTimestamp":1773599580,"startTime":"0","endTime":"0","summary":"On Friday, theS&P/ASX 200 Index finished the week with a small decline. The benchmark index fell 0.15% to 8,617.1 points.Will the market be able to bounce back from this on Monday?The Australian share market looks set for a disappointing start to the week following declines on Wall Street on Friday. According to the latest SPI futures, the ASX 200 is expected to open the day 61 points or 0.7% lower. In the United States, the Dow Jones was down 0.25%, the S&P 500 dropped 0.6%, and the Nasdaq tumbled 0.9%.The team at Wilsons thinks investors should be buying Cochlear Ltd  shares. It highlights that the hearing solution company's shares are trading at a material discount to long-term multiples. The broker said: \"Cochlear trades on a forward P/E multiple of ~26x, representing a >10 year low and a material discount to its 10-year average of ~42x. We view this as a compelling entry point for a high-quality business ahead of accelerating earnings growth.\"","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/16/5-things-to-watch-on-the-asx-200-on-monday-16-march-2026/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/16/5-things-to-watch-on-the-asx-200-on-monday-16-march-2026/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7015","BK7054","BK7142","WDS.AU","STO.AU","NEM.AU","CNU.AU","XJO.AU","HUB.AU","BK7007","BK7506","KCN.AU","BK7104","CMM.AU","COH.AU","BK7507","NST.AU","RMS.AU"],"gpt_icon":0},{"id":"2619872156","title":"26 ASX shares with ex-dividend dates next week","url":"https://stock-news.laohu8.com/highlight/detail?id=2619872156","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619872156?lang=en_us&edition=fundamental","pubTime":"2026-03-13 04:00","pubTimestamp":1773345600,"startTime":"0","endTime":"0","summary":"A large bunch of S&P/ASX All Ords Index (ASX: XAO) shares haveex-dividenddates coming up next week. In order to receive a dividend, you must own the ASX share before its ex-dividend date. As we've rep","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/13/26-asx-shares-with-ex-dividend-dates-next-week/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/13/26-asx-shares-with-ex-dividend-dates-next-week/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7506","HUB.AU","BK7093","BK7035","MAH.AU","KCN.AU","YAL.AU","CNU.AU","BK7055","COH.AU","BK7125","SPK.AU","BK7102","PL8.AU","SEK.AU","RMS.AU","PCG.AU","BK7061","BBL.AU","BK7054","CLX.AU","CMM.AU","A2M.AU","BK7083","BK7002","VIG","BK7031","BK4585","BK7095","CCP.AU","KLS.AU","FFI.AU","XAO.AU","KSC.AU","LFS.AU","BK7060","BK7062","DTL.AU","DUR.AU","BK7086","BK4588","BK7141","BK7015","AIA.AU","REH.AU","SNL.AU","BK7509","BK7042","BK7104","LGI.AU"],"gpt_icon":0},{"id":"2618928953","title":"IotaMotion Strengthens Leadership Position in Robotic Cochlear Implant Surgery with Issuance of New U.S. Patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2618928953","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618928953?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:38","pubTimestamp":1773236280,"startTime":"0","endTime":"0","summary":"ST. PAUL, Minn., March 11, 2026 /PRNewswire/ -- iotaMotion, Inc., the leader in robotic-assisted insertion systems for cochlear implantation and creator of iotaSOFT, the first and only FDA cleared robotic-assisted cochlear implant insertion system, today announced the issuance of U.S. Patent No. 12,558,123, further strengthening its intellectual property portfolio in robotic-assisted cochlear implantation.The iotaSOFT Robotic-Assisted Cochlear Implant Insertion System enables slow, consistent and controlled electrode insertion to preserve delicate intracochlear structures. FDA cleared for patients four years and older, the system addresses a major unmet need, as fewer than 5% of the 60 million people worldwide who could benefit from cochlear implants receive them.iotaMotion— the leader in robotic-assisted insertion systems for cochlear implantation and maker of the iotaSOFT Insertion System, the first and only FDA market authorized robotic-assisted insertion system, indicated for patie","market":"other","thumbnail":"https://mma.prnewswire.com/media/2931111/IOTAMOTION_INC__Robotic_Assisted_Cochlear_Implant_Insertion_System.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2931111/IOTAMOTION_INC__Robotic_Assisted_Cochlear_Implant_Insertion_System.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/iotamotion-strengthens-leadership-position-in-robotic-cochlear-implant-surgery-with-issuance-of-new-us-patent-302710523.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","LABU","COH.AU"],"gpt_icon":0},{"id":"1157525084","title":"Top 10 ASX 200 Stocks to Consider Following Market Downturn","url":"https://stock-news.laohu8.com/highlight/detail?id=1157525084","media":"Trading Random","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157525084?lang=en_us&edition=fundamental","pubTime":"2026-03-10 10:14","pubTimestamp":1773108866,"startTime":"0","endTime":"0","summary":"The ASX 200 index experienced a significant decline on Monday, driven by a sharp increase in oil prices amid escalating tensions in the Middle East.While such market corrections can be concerning in...","market":null,"thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Top 10 ASX 200 Stocks to Consider Following Market Downturn","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7016","BK7155","RMD.AU","BK7099","BK7510","PME.AU","BK7078","LU2008162690.USD","BK7511","GMG.AU","IE00B5TLWC47.USD","COH.AU","TNE.AU","BK4167","BK7503","LU2177674079.SGD","BK4588","BK7508","BK4504","BK4567","XRO.AU","BK7007","BK4585","BK7067","WTC.AU","CSL.AU","BK7501","BK4077","BK7002","LU0170899867.USD","REA.AU","LNW.AU","BK7094","BK4548","BK4082"],"gpt_icon":0},{"id":"2616731370","title":"What Cochlear (ASX:COH)'s Smart, Upgradeable Implant Launch in India Means For Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2616731370","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616731370?lang=en_us&edition=fundamental","pubTime":"2026-03-03 14:25","pubTimestamp":1772519157,"startTime":"0","endTime":"0","summary":"Cochlear has launched the Cochlear Nucleus Nexa System, described as the world's first smart cochlear implant with upgradeable firmware and on-implant memory for securely stored, personalized hearing settings, now available in India from 1 March 2026.\nThis marks a meaningful step in digitising hearing care, potentially making future sound processor upgrades simpler and more efficient for both patients and clinicians.\nWe’ll now examine how this smart, upgradeable implant platform could...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/what-cochlear-asxcohs-smart-upgradeable-implant-launch-in-in","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/what-cochlear-asxcohs-smart-upgradeable-implant-launch-in-in","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["COH.AU"],"gpt_icon":0},{"id":"2616804550","title":"Organic Growth in Australia's Healthcare Services Likely Due to Increased Availability of Bulk-Billing General Practitioners, Jefferies Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2616804550","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616804550?lang=en_us&edition=fundamental","pubTime":"2026-03-02 12:27","pubTimestamp":1772425659,"startTime":"0","endTime":"0","summary":"An organic growth in Australian healthcare services is likely due to improving availability of bulk-billing general practitioners, offset by ongoing wage pressures, Jefferies said in a Monday report.I","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IDX.AU","BK7089","CUV.AU","REG.AU","XBI","MSB.AU","BK7067","BK4588","HLS.AU","XLV","BK4585","BK7124","LABU","XJO.AU","ANN.AU","BK7126","NEU.AU","COH.AU","BK7501","NHF.AU","BK7508","CU6.AU","IMM.AU","BK7096","RHC.AU","XKO.AU","BK7103","CSL.AU","BK7511","TLX.AU","MVF.AU","MPL.AU","BK7007","FPH.AU","BK7113","SIG.AU","XAO.AU","HCAR","SHL.AU","BK4581","BK7509"],"gpt_icon":0},{"id":"2614183780","title":"Assessing Cochlear (ASX:COH) Valuation After Softer Half Year Results And Steady Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2614183780","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614183780?lang=en_us&edition=fundamental","pubTime":"2026-02-26 13:21","pubTimestamp":1772083307,"startTime":"0","endTime":"0","summary":"Cochlear (ASX:COH) has drawn fresh attention after reporting half year 2025 earnings that showed lower sales and net income than a year earlier, while keeping its interim dividend and payout ratio consistent.\nSee our latest analysis for Cochlear.\nAt around A$197.0 per share, Cochlear’s 1 day share price return of 2.07% sits against a 30 day share price decline of 28.03% and a 1 year total shareholder return decline of 24.66%, suggesting recent earnings and dividend news are being weighed...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/assessing-cochlear-asxcoh-valuation-after-softer-half-year-r","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/assessing-cochlear-asxcoh-valuation-after-softer-half-year-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","COH.AU","BK7007"],"gpt_icon":0},{"id":"2612444130","title":"Cochlear (ASX:COH) Holds Dividend as Profit Guidance Softens – What Is Management Signaling?","url":"https://stock-news.laohu8.com/highlight/detail?id=2612444130","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612444130?lang=en_us&edition=fundamental","pubTime":"2026-02-18 21:17","pubTimestamp":1771420627,"startTime":"0","endTime":"0","summary":"Cochlear Limited recently reported half-year 2025 results showing largely flat sales of A$1,167.2 million but lower net income of A$161.5 million and reduced earnings per share versus the prior year.\nAt the same time, the company held its interim franked dividend steady at A$2.15 per share, implying management’s desire to signal confidence despite Nexa rollout and contracting challenges pressuring profit and guidance.\nWe’ll now examine how weaker profit guidance, tied to delays in Nucleus...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-asxcoh-holds-dividend-as-profit-guidance-softens-wh","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-asxcoh-holds-dividend-as-profit-guidance-softens-wh","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK4585","BK4528","COH.AU","BK4023","BK7007","BK4551","BK4587","BK4543","AI"],"gpt_icon":0},{"id":"2612458671","title":"Cochlear (ASX:COH) Valuation After Profit Drop Nexa Delays And Lowered Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2612458671","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612458671?lang=en_us&edition=fundamental","pubTime":"2026-02-17 16:16","pubTimestamp":1771316188,"startTime":"0","endTime":"0","summary":"Cochlear (ASX:COH) is back in focus after its half year result showed net income of A$161.5 million and a lower full year profit outlook, alongside contracting delays for the new Nucleus Nexa system.\nSee our latest analysis for Cochlear.\nThe sharp post earnings selloff has left Cochlear at a share price of A$199.81, with a 7 day share price return of 22.22% and a 1 year total shareholder return of 25.96%. This signals fading momentum as investors reassess risks around Nexa adoption and the...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-asxcoh-valuation-after-profit-drop-nexa-delays-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-asxcoh-valuation-after-profit-drop-nexa-delays-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7007","COH.AU"],"gpt_icon":0},{"id":"2611210805","title":"Cochlear (ASX:COH) Has Affirmed Its Dividend Of A$2.15","url":"https://stock-news.laohu8.com/highlight/detail?id=2611210805","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611210805?lang=en_us&edition=fundamental","pubTime":"2026-02-16 09:28","pubTimestamp":1771205315,"startTime":"0","endTime":"0","summary":"Cochlear Limited's ( ASX:COH ) investors are due to receive a payment of A$2.15 per share on 13th of April. This means...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-asxcoh-has-affirmed-its-dividend-of-a215","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-asxcoh-has-affirmed-its-dividend-of-a215","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7007","COH.AU"],"gpt_icon":0},{"id":"2611797631","title":"Cochlear Bull Thinks Selloff Was Emotion-Driven -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2611797631","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611797631?lang=en_us&edition=fundamental","pubTime":"2026-02-16 07:35","pubTimestamp":1771198500,"startTime":"0","endTime":"0","summary":"2335 GMT - Cochlear's bull at Canaccord Genuity sees nothing in its operations to justify the size of the selloff that followed the hearing-tech provider's 1H profit miss. Analyst Shane Storey keeps a buy rating on the Australia-listed stock, telling clients in a note that a 19% share-price fall seems extreme on a 5% net profit miss. Shareholder emotion and frustration are the only reasons he can give to explain the drop. Storey observes that the selloff took the company's earnings multiple to a 10-year low and sees this as a buying opportunity that echoes one sparked in 2011 by a product recall. Canaccord Genuity cuts its target price 11% to A$295.00. Shares are up 2.7% at A$204.68. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","COH.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":61,"code":"91000000","status":"200"}]}}